Rising Levels of Human Cytomegalovirus (HCMV) Antigenemia during Initial Antiviral Treatment of Solid-Organ Transplant Recipients with Primary HCMV Infection

Documenti analoghi

• Standardization of the Human Cytomegalovirus Antigenemia Assay by Means of In Vitro-Generated pp65-Positive Peripheral Blood Polymorphonuclear Leukocytes
  di: Gerna, Giuseppe, et al.
  Pubblicazione: (1998)
• Quantification of Human Cytomegalovirus DNA in Amniotic Fluid of Mothers of Congenitally Infected Fetuses
  di: Revello, Maria Grazia, et al.
  Pubblicazione: (1999)
• Clinical Significance of Expression of Human Cytomegalovirus pp67 Late Transcript in Heart, Lung, and Bone Marrow Transplant Recipients as Determined by Nucleic Acid Sequence-Based Amplification
  di: Gerna, Giuseppe, et al.
  Pubblicazione: (1999)
• Prenatal Diagnosis of Congenital Human Cytomegalovirus Infection in Amniotic Fluid by Nucleic Acid Sequence-Based Amplification Assay
  di: Revello, M. Grazia, et al.
  Pubblicazione: (2003)
• Human Cytomegalovirus and Human Umbilical Vein Endothelial Cells: Restriction of Primary Isolation to Blood Samples and Susceptibilities of Clinical Isolates from Other Sources to Adaptation
  di: Gerna, Giuseppe, et al.
  Pubblicazione: (2002)